Search Results 531-540 of 109037 for b-

  1. Publications - Michael B. Colgan, M.D. - Mayo Clinic

    2010 Nov; 163(5):1095-8. View PubMed; Plaza JA, Comfere NI, Gibson LE, Colgan M, Davis DM, Pittelkow MR, Colgan JP. Unusual cutaneous manifestations of B ...

  2. Publications - Harold B. Kitaoka, M.D. - Mayo Clinic

    Huang YC, Harbst K, Kotajarvi B, Hansen D, Koff MF, Kitaoka HB, Kaufman KR. Effects of ankle-foot orthoses on ankle and foot kinematics in patients with ...

  3. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

    ... B, Matika R, Miles G, Mukhopadhyay S, Nichols JH, O'Dell RM, Rafique Z ... B, Cheville AL, Gajic O, Kor DJ. Practical Anemia Bundle and Hemoglobin ...

  4. Mohamad Bassam Sonbol, M.D. - Doctors and Medical Staff - Mayo Clinic

    Mohamad Bassam Sonbol, M.D., is a medical oncologist at Mayo Clinic in Arizona, with clinical and research expertise in gastrointestinal malignancies and ...

  5. Hodgkin lymphoma (Hodgkin disease) - Symptoms and causes - Mayo Clinic

    Hodgkin lymphoma starts in germ-fighting white blood cells called B lymphocytes. Hodgkin lymphoma is highly treatable and often curable. Treatments for ...

  6. News - Sarosh R. Irani, B.M., B.Ch., D.Phil. - Mayo Clinic

    Sarosh R. Irani, B.M., B.Ch., D.Phil. Neurologist. Request an Appointment.

  7. Publications - Jeffrey B. Jensen, M.D. - Mayo Clinic

    2014; 9(1). Karpman C, Keegan MT, Jensen JB, Bauer PR, Brown DR, Afessa B. The impact of rapid response team on outcome of patients ...

  8. A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) - Mayo Clinic

    A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) · Overview · Participation eligibility · Participating Mayo Clinic ...

  9. Genotype Optimal Regimens 1 GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ES

    b-Decomp cirrhosis, and SOF or NS5A failure, add RBV 24 wks. EBV/GZV 12 wks a-In G1a check RAVs to NS5A, if + 16 wks b-NS3A/PI+PEG-IFN/RBV TE, add RBV, and ...

  10. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    The primary objective of this study is to evaluate the clinical effectiveness of different investigational therapeutics relative to the control arm in adults ...